The 4 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +262.90% increase from the last price of 1.24.
The current consensus among 4 polled investment analysts is to Buy stock in Dare Bioscience Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Apr 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.